Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

79.82 

5.15 6.6%

as of Sep 30 '20

52 Week Range:

50.99 87.79


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 5.10
1.90
1.98
2.16
2.19
3.16
3.75
4.24
5.03
5.39
6.08
growth rate -62.8% 4.2% 9.1% 1.4% 44.3% 18.7% 13.1% 18.6% 7.2% 12.8%
Earnings BIT 304.40
268.20
283.60
391.10
515.30
494.80
642.90
819.40
1,022.40
1,072.80
1,240.50
growth rate -11.9% 5.7% 37.9% 31.8% -4.0% 29.9% 27.5% 24.8% 4.9% 15.6%
Avg.PE 22.27
44.25
35.71
36.36
19.12
17.78
39.08
36.31
46.77
52.25
67.45
growth rate 98.7% -19.3% 1.8% -47.4% -7.0% 119.8% -7.1% 28.8% 11.7% 29.1%
ROA 15.19
12.89
12.63
13.96
15.84
25.96
13.05
13.29
11.44
13.11
17.73
growth rate -15.1% -2.0% 10.5% 13.5% 63.9% -49.7% 1.8% -13.9% 14.6% 35.2%
ROE 22.50
17.68
17.89
20.82
25.78
43.25
21.08
22.24
20.94
23.69
28.73
growth rate -21.4% 1.2% 16.4% 23.8% 67.8% -51.3% 5.5% -5.9% 13.1% 21.3%
ROIC 19.97
17.20
16.05
18.56
20.71
33.14
17.05
17.60
14.58
20.21
24.14
growth rate -13.9% -6.7% 15.6% 11.6% 60.0% -48.6% 3.2% -17.2% 38.6% 19.5%
Cur. Ratio 3.06
3.06
3.49
3.72
4.99
5.28
4.30
4.21
1.80
2.61
3.31
growth rate 0.0% 14.1% 6.6% 34.1% 5.8% -18.6% -2.1% -57.2% 45.0% 26.8%
Quick Ratio 2.09
2.07
2.30
2.50
3.66
4.06
3.29
3.17
1.28
1.70
2.34
growth rate -1.0% 11.1% 8.7% 46.4% 10.9% -19.0% -3.7% -59.6% 32.8% 37.7%
Leverage 1.40
1.35
1.48
1.50
1.75
1.61
1.62
1.72
1.93
1.70
1.56
growth rate -3.6% 9.6% 1.4% 16.7% -8.0% 0.6% 6.2% 12.2% -11.9% -8.2%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 249.40
277.30
364.60
390.90
361.40
325.00
371.80
414.60
479.30
537.30
599.10
growth rate 11.2% 31.5% 7.2% -7.6% -10.1% 14.4% 11.5% 15.6% 12.1% 11.5%
Acct.Payable 335.20
347.40
345.60
58.20
63.90
97.10
116.60
134.00
180.40
growth rate 3.6% -0.5% -83.2% 9.8% 52.0% 20.1% 14.9% 34.6%
Cur.Assets 889.20
1,032.60
1,168.50
1,291.90
1,725.80
2,231.10
2,047.90
2,240.00
2,549.20
2,286.90
2,984.00
growth rate 16.1% 13.2% 10.6% 33.6% 29.3% -8.2% 9.4% 13.8% -10.3% 30.5%
Total Assets 1,615.50
1,767.20
1,980.50
2,221.50
2,709.90
3,523.00
4,056.30
4,510.00
5,666.40
5,323.70
6,488.10
growth rate 9.4% 12.1% 12.2% 22.0% 30.0% 15.1% 11.2% 25.6% -6.1% 21.9%
Cash 334.10
396.10
171.20
310.90
420.40
653.80
718.40
930.10
818.30
714.10
1,179.10
growth rate 18.6% -56.8% 81.6% 35.2% 55.5% 9.9% 29.5% -12.0% -12.7% 65.1%
Inventory 165.90
203.60
261.30
281.00
308.90
296.80
339.90
396.60
554.90
607.00
640.90
growth rate 22.7% 28.3% 7.5% 9.9% -3.9% 14.5% 16.7% 39.9% 9.4% 5.6%
Cur.Liabilities 290.50
337.80
335.20
347.40
345.60
426.10
476.20
532.50
1,420.00
876.60
902.40
growth rate 16.3% -0.8% 3.6% -0.5% 23.3% 11.8% 11.8% 166.7% -38.3% 2.9%
Liabilities 457.60
459.00
642.60
742.20
1,165.50
1,331.60
1,553.20
1,891.00
2,710.20
2,183.30
2,339.80
growth rate 0.3% 40.0% 15.5% 57.0% 14.3% 16.6% 21.8% 43.3% -19.4% 7.2%
LT Debt 90.30
0.00
150.40
189.30
593.10
598.10
596.90
822.30
438.40
593.80
594.40
growth rate -100.0% 25.9% 213.3% 0.8% -0.2% 37.8% -46.7% 35.5% 0.1%
Equity 1,157.90
1,308.20
1,337.90
1,479.30
1,544.40
2,191.40
2,503.10
2,619.00
2,956.20
3,140.40
4,148.30
growth rate 13.0% 2.3% 10.6% 4.4% 41.9% 14.2% 4.6% 12.9% 6.2% 32.1%
Common Shares 235.00
715.00
716.00
709.00
682.00
651.00
660.00
653.00
648.00
640.00
637.00
growth rate 204.3% 0.1% -1.0% -3.8% -4.6% 1.4% -1.1% -0.8% -1.2% -0.5%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 64.00
63.00
76.60
109.00
109.00
82.90
102.70
176.10
168.10
238.70
254.40
growth rate -1.6% 21.6% 42.3% 0.0% -23.9% 23.9% 71.5% -4.5% 42.0% 6.6%
Cash Dividends 0.00 0.00 0.00 0.00
growth rate
Cash From OA 165.30
251.40
308.20
362.10
472.70
1,022.30
549.70
704.40
1,000.70
926.80
1,179.40
growth rate 52.1% 22.6% 17.5% 30.5% 116.3% -46.2% 28.1% 42.1% -7.4% 27.3%
FCF per Share 0.43
0.26
0.27
0.35
0.49
1.49
0.65
0.63
1.00
1.18
1.27
growth rate -39.5% 3.9% 29.6% 40.0% 204.1% -56.4% -3.1% 58.7% 18.0% 7.6%
Sale Purchase of Stock -243.90
-244.00
-451.40
113.30
87.20
103.30
113.80
growth rate 0.0% 0.0% 100.0% -23.0% 18.5% 10.2%
FCF 101.00
188.00
224.00
246.00
363.00
929.00
443.00
487.00
825.00
685.00
901.00
growth rate 86.1% 19.2% 9.8% 47.6% 155.9% -52.3% 9.9% 69.4% -17.0% 31.5%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 1,321.40
1,447.00
1,678.60
1,899.60
2,045.50
2,322.90
2,493.70
2,963.70
3,435.30
3,722.80
4,348.00
growth rate 9.5% 16.0% 13.2% 7.7% 13.6% 7.4% 18.9% 15.9% 8.4% 16.8%
Op.Income 301.80
284.30
236.70
291.50
389.10
494.80
642.90
819.40
1,022.40
1,072.80
1,240.50
growth rate -5.8% -16.7% 23.2% 33.5% 27.2% 29.9% 27.5% 24.8% 4.9% 15.6%
IBT 304.40
268.20
283.60
388.20
511.20
1,144.00
622.40
737.90
1,034.90
761.40
1,166.50
growth rate -11.9% 5.7% 36.9% 31.7% 123.8% -45.6% 18.6% 40.3% -26.4% 53.2%
Net Income 229.10
218.00
236.70
291.50
389.10
811.10
494.90
569.50
583.60
722.20
1,046.90
growth rate -4.9% 8.6% 23.2% 33.5% 108.5% -39.0% 15.1% 2.5% 23.8% 45.0%
EPS 0.97
0.30
0.33
0.41
0.57
1.25
0.75
0.87
0.90
1.13
1.64
growth rate -69.1% 10.0% 24.2% 39.0% 119.3% -40.0% 16.0% 3.5% 25.6% 45.1%
Gross Profit 922.30
1,038.70
1,188.80
1,408.60
1,528.90
1,699.30
1,876.50
2,166.30
2,560.00
2,783.40
3,233.60
growth rate 12.6% 14.5% 18.5% 8.5% 11.2% 10.4% 15.4% 18.2% 8.7% 16.2%
R&D 175.50
204.40
246.30
291.30
323.00
346.50
382.90
442.20
552.60
622.20
752.70
growth rate 16.5% 20.5% 18.3% 10.9% 7.3% 10.5% 15.5% 25.0% 12.6% 21.0%

Quarterly Statements

Item Name Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Earnings BIT 282.50
299.90
346.60
368.40
229.80
growth rate 6.2% 15.6% 6.3% -37.6%
Balance Sheet Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Acct.Receivable 609.60
570.00
599.10
585.10
567.90
growth rate -6.5% 5.1% -2.3% -2.9%
Acct.Payable 151.00
135.90
180.40
151.50
153.40
growth rate -10.0% 32.7% -16.0% 1.3%
Cur.Assets 2,354.70
2,739.70
2,984.00
2,507.90
2,690.30
growth rate 16.4% 8.9% -16.0% 7.3%
Total Assets 5,573.50
5,966.30
6,488.10
6,076.10
6,424.10
growth rate 7.1% 8.8% -6.4% 5.7%
Cash 726.80
1,186.60
1,179.10
662.90
903.50
growth rate 63.3% -0.6% -43.8% 36.3%
Inventory 624.90
611.10
640.90
662.20
735.10
growth rate -2.2% 4.9% 3.3% 11.0%
Cur.Liabilities 697.00
775.80
902.40
746.90
873.20
growth rate 11.3% 16.3% -17.2% 16.9%
Liabilities 2,073.20
2,151.50
2,339.80
2,175.00
2,585.00
growth rate 3.8% 8.8% -7.0% 18.9%
LT Debt 594.10
594.20
594.40
594.60
594.70
growth rate 0.0% 0.0% 0.0% 0.0%
Equity 3,500.30
3,814.80
4,148.30
3,901.10
3,839.10
growth rate 9.0% 8.7% -6.0% -1.6%
Common Shares 216.90
217.50
218.10
218.50
633.50
growth rate 0.3% 0.3% 0.2% 189.9%
Cash Flow Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Capital Expenditures 64.60
76.10
71.50
82.20
108.30
growth rate 17.8% -6.0% 15.0% 31.8%
Cash Dividends
growth rate
Cash From OA 341.20
437.30
399.40
207.00
231.20
growth rate 28.2% -8.7% -48.2% 11.7%
Sale Purchase of Stock
growth rate
FCF 276.60
361.20
327.90
124.80
122.90
growth rate 30.6% -9.2% -61.9% -1.5%
Income Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Sales 1,086.90
1,094.00
1,174.10
1,128.70
925.00
growth rate 0.7% 7.3% -3.9% -18.1%
Op.Income 282.50
299.90
346.60
368.40
229.80
growth rate 6.2% 15.6% 6.3% -37.6%
IBT 271.30
301.70
315.50
364.50
-168.20
growth rate 11.2% 4.6% 15.5% -100.0%
Net Income 242.30
274.70
280.20
310.60
-121.90
growth rate 13.4% 2.0% 10.9% -100.0%
EPS
growth rate
Gross Profit 782.90
801.60
887.90
863.60
686.80
growth rate 2.4% 10.8% -2.7% -20.5%
R&D 191.90
195.50
193.90
187.40
182.10
growth rate 1.9% -0.8% -3.4% -2.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A+ (93.90)

YOY Growth Grade:

B (72.87)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 66.41 67.82 35.37
EPS / Growth 25.8% 1.18 12.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 17.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 12.2% 18.3% 18.3%
Future PE 24.34 46.15 46.15
Future EPS 3.71 6.33 6.33
Value Price
MOS %
22.33
-72.0%
72.26
-9.5%
72.26
-9.5%
MOS Price 11.17 36.13 36.13
IRT 18.47 14.49 14.49

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.